Paper40435237
Deciphering linezolid-induced hematologic toxicity: Targeting TOP2A and TOP2B via its primary metabolite PNU142586.
Thu VTA and 10 others. Sci Adv, 2025. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Deciphering linezolid-induced hematologic toxicity: Targeting TOP2A and TOP2B via its primary metabolite PNU142586. Papers, record 40435237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40435237
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Deciphering linezolid-induced hematologic toxicity: Targeting TOP2A and TOP2B via its primary metabolite PNU142586.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Linezolid | Major topic |
| DNA Topoisomerases, Type II | Major topic |
| Hematologic Diseases | Major topic |
| Topoisomerase II Inhibitors | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Male | |
| Female | |
| Anti-Bacterial Agents | |
| Poly-ADP-Ribose Binding Proteins |
Source PubMed
References113
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25277948 | Tools for in silico target fishing. | Methods | 2015 | https://conductscience.org/library/papers/25277948 | PubMed |
| 2 | 36565357 | Linezolid pharmacokinetics: a systematic review for the best clinical practice. | Eur J Clin Pharmacol | 2023 | https://conductscience.org/library/papers/36565357 | PubMed |
| 3 | 18757750 | The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18757750 | PubMed |
| 4 | 9651360 | Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavage. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9651360 | PubMed |
| 5 | 14519130 | A truncated form of DNA topoisomerase IIbeta associates with the mtDNA genome in mammalian mitochondria. | Eur J Biochem | 2003 | https://conductscience.org/library/papers/14519130 | PubMed |
| 6 | 11346064 | Linezolid for the treatment of resistant gram-positive cocci. | Ann Pharmacother | 2001 | https://conductscience.org/library/papers/11346064 | PubMed |
| 7 | 19075058 | Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19075058 | PubMed |
| 8 | 29263063 | Mitochondrial Alterations (Inhibition of Mitochondrial Protein Expression, Oxidative Metabolism, and Ultrastructure) Induced by Linezolid and Tedizolid at Clinically Relevant Concentrations in Cultured Human HL-60 Promyelocytes and THP-1 Monocytes. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29263063 | PubMed |
| 9 | 16774814 | In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates. | Int J Antimicrob Agents | 2006 | https://conductscience.org/library/papers/16774814 | PubMed |
| 10 | 29321287 | Isolation of Xenopus Oocytes. | Cold Spring Harb Protoc | 2018 | https://conductscience.org/library/papers/29321287 | PubMed |
| 11 | 24732289 | Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis. | PLoS One | 2014 | https://conductscience.org/library/papers/24732289 | PubMed |
| 12 | 8835391 | Characterization of Xenopus laevis oocyte farnesyl transferase. | Biol Reprod | 1996 | https://conductscience.org/library/papers/8835391 | PubMed |
| 13 | 31625720 | Use of Zebrafish in Drug Discovery Toxicology. | Chem Res Toxicol | 2020 | https://conductscience.org/library/papers/31625720 | PubMed |
| 14 | 31027213 | Twist and Turn-Topoisomerase Functions in Mitochondrial DNA Maintenance. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31027213 | PubMed |
| 15 | 34192814 | Effect of renal function on the risk of thrombocytopaenia in patients receiving linezolid therapy: A systematic review and meta-analysis. | Br J Clin Pharmacol | 2022 | https://conductscience.org/library/papers/34192814 | PubMed |
| 16 | 16127068 | Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/16127068 | PubMed |
| 17 | 31592646 | Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets. | J Med Chem | 2020 | https://conductscience.org/library/papers/31592646 | PubMed |
| 18 | 14638510 | Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/14638510 | PubMed |
| 19 | 23757188 | DNA topoisomerase IIα controls replication origin cluster licensing and firing time in Xenopus egg extracts. | Nucleic Acids Res | 2013 | https://conductscience.org/library/papers/23757188 | PubMed |
| 20 | 28584143 | Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28584143 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42429417 | Synergism in drug combination of new tuberculosis antibiotics for drug-resistant Mycobacterium tuberculosis in vitro. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42429417 | PubMed |
| 42406070 | Off-target anti-leukemic effects of antibiotics: mechanisms and therapeutic insights. | Cancer Chemother Pharmacol | 2026 | https://conductscience.org/library/papers/42406070 | PubMed |
| 42404710 | Design, Synthesis and Biological Evaluation of New Oxazolidinone Antimicrobial Agents with Low Monoamine Oxidase A Inhibition. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42404710 | PubMed |
| 42310648 | Simultaneous quantification of linezolid and its metabolites (PNU-142300 and PNU-142586) in oral fluid and capillary blood by UPLC-MS/MS: method validation and clinical application using non-invasive sampling techniques. | J Transl Med | 2026 | https://conductscience.org/library/papers/42310648 | PubMed |
| 41471310 | A Unified Approach to Synthesizing Four Linezolid Metabolites That May Cause Thrombocytopenia. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41471310 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TOP2A | 7153 | PubTator's text mining | https://conductscience.org/library/genes/7153 | NCBI Gene |
| TOP2B | 7155 | PubTator's text mining | https://conductscience.org/library/genes/7155 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40435237
GET https://conductscience.org/api/papers/v1/40435237/references?page=2